» Articles » PMID: 31256115

The Cancer Cell Glycocalyx Proteoglycan Glypican-1 Mediates Interstitial Flow Mechanotransduction to Enhance Cell Migration and Metastasis

Overview
Journal Biorheology
Publisher Sage Publications
Specialty Biophysics
Date 2019 Jul 1
PMID 31256115
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies have demonstrated that the glycosaminoglycans (GAGs) heparan sulfate (HS) and hyaluronic acid (HA) are mechanosensors for interstitial flow on cancer cells. The proteins that link the GAGs to the cancer cell for mechanotransduction, however, are not known.

Objective: To assess whether the HS proteoglycan core proteins, Glypican-1 and Syndecan-1, or the HA receptor, CD44, provides the mechanical linkage to the cell.

Methods: The highly metastatic renal carcinoma cell line (SN12L1) and its companion low metastatic cell line (SN12C) were analyzed by Western blot, siRNA, and a 3-dimensional interstitial flow migration assay.

Results: There was significant elevation of Glypican-1 protein expression in the SN12L1 cells relative to the SN12C cells while there were no significant differences in Syndecan-1 or CD44. Knock down of Glypican-1 by siRNA completely blocked flow induced migration in SN12L1 cells. MAPK inhibitors also blocked flow induced migration in SN12L1 cells.

Conclusions: Glypican-1 provides the mechanical linkage from HS (the flow sensor) to the SN12L1 cell where mechanotransduction leading to the enhancement of migration (metastasis) occurs. MAPKs downstream of Glypican-1 propagate the signal. The HS, Glypican-1, MAPK signaling axis suggests opportunities for pharmaceutical intervention.

Citing Articles

Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression.

Zhu Y, Chen J, Chen C, Tang R, Xu J, Shi S Biomark Res. 2025; 13(1):11.

PMID: 39849659 PMC: 11755887. DOI: 10.1186/s40364-025-00727-9.


When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression.

Habeeb I, Alao T, Delgado D, Buffone Jr A Front Oncol. 2024; 14:1487306.

PMID: 39628991 PMC: 11611868. DOI: 10.3389/fonc.2024.1487306.


Atomic Force Microscopy and Scanning Ion-Conductance Microscopy for Investigation of Biomechanical Characteristics of Neutrophils.

Shvedov M, Sherstyukova E, Kandrashina S, Inozemtsev V, Sergunova V Cells. 2024; 13(21.

PMID: 39513864 PMC: 11545488. DOI: 10.3390/cells13211757.


Cell Surface Parameters for Accessing Neutrophil Activation Level with Atomic Force Microscopy.

Tilinova O, Inozemtsev V, Sherstyukova E, Kandrashina S, Pisarev M, Grechko A Cells. 2024; 13(4.

PMID: 38391919 PMC: 10886474. DOI: 10.3390/cells13040306.


Theranostic Applications of Glycosaminoglycans in Metastatic Renal Cell Carcinoma.

Hua S, Viera M, Yip G, Bay B Cancers (Basel). 2023; 15(1).

PMID: 36612261 PMC: 9818616. DOI: 10.3390/cancers15010266.